433 related articles for article (PubMed ID: 8600055)
1. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia.
Ochiai A; Yamauchi Y; Hirohashi S
Int J Cancer; 1996 Feb; 69(1):28-33. PubMed ID: 8600055
[TBL] [Abstract][Full Text] [Related]
2. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
Gomyo Y; Osaki M; Kaibara N; Ito H
Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
[TBL] [Abstract][Full Text] [Related]
3. p53 alteration in gastric precancerous lesions.
Shiao YH; Rugge M; Correa P; Lehmann HP; Scheer WD
Am J Pathol; 1994 Mar; 144(3):511-7. PubMed ID: 8129036
[TBL] [Abstract][Full Text] [Related]
4. In situ analysis of tissue dynamics and p53 expression in human gastric mucosa.
Imatani A; Sasano H; Yabuki N; Kato K; Ohara S; Asaki S; Toyota T; Nagura H
J Pathol; 1996 May; 179(1):39-42. PubMed ID: 8691342
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach.
Kim SS; Bhang CS; Min KO; Chae HS; Choi SW; Lee CD; Lim KW; Chung IS; Park DH
J Korean Med Sci; 2002 Aug; 17(4):490-6. PubMed ID: 12172044
[TBL] [Abstract][Full Text] [Related]
6. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
[TBL] [Abstract][Full Text] [Related]
7. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
Agoston AT; Odze RD
Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
[TBL] [Abstract][Full Text] [Related]
8. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis.
Mingchao ; Devereux TR; Stockton P; Sun K; Sills RC; Clayton N; Portier M; Flake G
Exp Toxicol Pathol; 2001 Sep; 53(4):237-46. PubMed ID: 11665847
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between mitochondrial DNA instability and interleukin-8 activity in gastric mucosa].
Ling XL; Fang DC; Wang RQ; Yang SM; Luo YH
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):35-7. PubMed ID: 12760801
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
11. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia.
Szoke D; Molnár B; Solymosi N; Sipos F; Galamb O; Gyorffy A; Tulassay Z
Dig Liver Dis; 2009 Mar; 41(3):179-84. PubMed ID: 18567547
[TBL] [Abstract][Full Text] [Related]
12. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement.
Solcia E; Fiocca R; Luinetti O; Villani L; Padovan L; Calistri D; Ranzani GN; Chiaravalli A; Capella C
Am J Surg Pathol; 1996; 20 Suppl 1():S8-22. PubMed ID: 8694148
[TBL] [Abstract][Full Text] [Related]
13. [Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
Ai Zheng; 2006 Feb; 25(2):185-9. PubMed ID: 16480583
[TBL] [Abstract][Full Text] [Related]
14. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
[TBL] [Abstract][Full Text] [Related]
15. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
16. Frequent translocalization of beta-catenin in gastric cancers and its relevance to tumor progression.
Cheng XX; Sun Y; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Oncol Rep; 2004 Jun; 11(6):1201-7. PubMed ID: 15138556
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
Vernygorodskyi S
Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
[TBL] [Abstract][Full Text] [Related]
18. p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection.
Marinone C; Martinetti A; Mestriner M; Seregni E; Geuna M; Ferrari L; Strola G; Bonardi L; Fea E; Bombardieri E
Anticancer Res; 2001; 21(2A):1115-8. PubMed ID: 11396149
[TBL] [Abstract][Full Text] [Related]
19. [High frequency mutation of p53 gene in human gastric cancer and precancerous lesions].
Li Z; Lü Y
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):90-3. PubMed ID: 10920952
[TBL] [Abstract][Full Text] [Related]
20. Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.
Karim S; Ali A
World J Gastroenterol; 2009 Mar; 15(11):1381-7. PubMed ID: 19294769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
